@vandaaginside tijdens het spectaculaire dansen van Johan Derksen zojuist, zag ik hem met twee beelden van de dikke en de dunne zwaaien. Ben er al járen naar op zoek! Waar kan ik die vinden????? Groetjes,Clio
Looking forward to attending this year's Annual @ISOQOL conference in Cologne for the next three days, October 13-16. Great agenda and roster of speakers. Looking also forward to learning a lot and meeting new people
@PostNL de bezorger is al bijna twee weken onderweg om mijn pakketje te bezorgen… dat is toch zeker een grapje. Daan, jullie chatbot is ook t spoor bijster.
As a result of no participation from the Netherlands in the Eurovision Song Contest Grand Final the following will take effect:
All contestants keep their number in the official Running Order. There will be NO song in position number 5.
The jury results, received after Dress Rehearsal 2 on Friday 10 May have been recalculated so that the Netherlands will not receive any points. This is why all jury members have to rank all songs from 1 to 26.
For example if the Netherlands was ranked 9th by a national jury in a country the 10th ranked song is now ranked 9th and will receive 2 points and the former 11th ranked song is now 10th and gets 1 point.
No points will be awarded to the Netherlands from the viewing public.
Viewers in the Netherlands are still allowed to vote in the Grand Final and the Netherlands Jury result in still valid.
The EBU will inform all telecommunications partners that the Netherlands is no longer participating, and we will endeavor to block the lines for Song 5. We ask that no one attempts to vote for Song 5. Should anyone try to vote for song 5 their votes will not count but there is a possibly viewers may be charged.
The Netherlands will not appear on the scoreboard.
Visit this link for more information: https://t.co/MMS5eih3bC
The new EU pharmaceutical legislation will be guided by 3 A's, i.e. Affordability, Accessability and Availabilitym and 3 S's: Sustainability, Solidarity and Social contract #HEOR#CQfluency#ISPOREurope
For the 2020 EU legislation revision for pharma, 4 pillars were identified: 1. make medicines affordable to all; 2. foster sustainability and competitive innovation; 3. strong EU voice globally and 4. increased preparedness for crises. #ISPOREurope#healthcare#HEOR
The EU pharmaceutical legislation originates from 1965, and was updated in 2004. In 2020 in light of COVID-19 and as part of the EU pharma strategy, the Commission planned another revision of the general EU legislation of medicines for human use. #ISPOREurope#healthcare#HEOR
#ISPOREurope President of @ISPORorg sharing the presidential vision on thee 2024 strategy. Value driven innovation, increase passion in the different disciplines, training, education and more #healthcare#HEOR
@GatesMRI speaking about Women's Health R&D and focusing on sex and gender as important factors influencing health outcomes. We are still dealing with gender inequity and this cycle needs to be broken, but where to start? @ISPORorg@CQfluency
The caveats of SLR (Systematic Literature Review): lack of transparency used by AI for decision-making (black-box), AI dependency on biasness in the training set and ethical implications. @ISPORorg@CQfluency
Did you know that according to @Parexel approximately 70% of adults in the USA have concerns about the increase use of AI in healthcare and that younger patients are more willing to engage? @ISPORorg@CQfluency
From @Parexel a refresher on the definition of Evergreen (aka Living) Evidence: the continuous integration of new data allowing for dynamic decision-making that reflects real-world health care outcomes over time. @ISPORorg